Glucose Health, Inc. (GLUC)
OTCMKTS
· Delayed Price · Currency is USD
0.361
-0.039 (-9.75%)
Apr 27, 2026, 4:00 PM EST
Glucose Health Revenue
Glucose Health had revenue of $340.68K in the quarter ending September 30, 2022, with 18.66% growth. This brings the company's revenue in the last twelve months to $1.11M, up 131.47% year-over-year. In the year 2021, Glucose Health had annual revenue of $953.68K with 98.39% growth.
Revenue (ttm)
1.11M
Revenue Growth
+131.47%
P/S Ratio
9.34
Revenue / Employee
370.90K
Employees
3
Market Cap
10.39M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 953.68K | 472.97K | 98.39% |
| Dec 31, 2020 | 480.71K | 167.48K | 53.47% |
| Dec 31, 2016 | 313.23K | 308.96K | 7,232.14% |
| Dec 31, 2015 | 4.27K | 1.53K | 55.97% |
| Dec 31, 2014 | 2.74K | 2.52K | 1,122.77% |
| Dec 31, 2013 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
| Dec 31, 2009 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Integrated BioPharma | 52.09M |
| China Foods Holdings | 327.87K |
| BAB, Inc. | 3.41M |
| Strake | 223.07K |
| GPO Plus | 5.19M |
| Next Meats Holdings | 1.05M |
| DAVIDsTEA | 43.33M |
| Steakholder Foods | 10.00K |
Glucose Health News
- 7 weeks ago - Glucose Health Expands Retail Distribution to 2,500+ Stores, Launches National Advertising Campaign - GlobeNewsWire
- 3 months ago - Glucose Health, Inc. Reports Debt-Free Balance Sheet and Previews New Soluble Fiber Brand - GlobeNewsWire
- 3 months ago - Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy - GlobeNewsWire
- 4 months ago - Glucose Health, Inc. Completes Preferred Stock Conversion at an 85% Premium Positioning Company for Rapid Growth - GlobeNewsWire
- 6 months ago - Glucose Health, Inc. Appoints Strategic Investor Christopher J. Jemapete to Its Board of Directors - GlobeNewsWire
- 6 months ago - Glucose Health, Inc. Appoints Veteran Financial Executive Edmund “Ned” Burke to Its Board of Directors - GlobeNewsWire
- 7 months ago - Glucose Health, Inc. Announces Officer Changes Effective September 30, 2025 - GlobeNewsWire
- 9 months ago - Glucose Health, Inc. (OTC: GLUC) Highlights U.S. Department of Health and Human Services Designation of Key Nutrient Validating Company's Patent-Pending Nutrition Formulation via CNBC, Fox Business and Bloomberg Television Media Blitz - GlobeNewsWire